Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-01

Clinical Trial Update: A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC. [NA]

View source ↗

Summary

A prospective, single-center study at Universitair Ziekenhuis Brussel enrolling about 570 patients for genetic screening; patients with SCN4A or CLCN1 variants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non Dystrophic Myotonia, Arrythmia, Cardiac | NA | Status: NOT_YET_RECRUITING